Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Imago Biosciences Inc (NQ: IMGO )

14.98 +0.50 (+3.45%)
Streaming Delayed Price Updated: 10:40 AM EDT, May 26, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,020
Open 14.70
Bid (Size) 14.91 (2)
Ask (Size) 15.08 (3)
Prev. Close 14.48
Today's Range 14.07 - 14.98
52wk Range 12.85 - 35.68
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
70 Biggest Movers From Friday
Gainers GTY Technology Holdings Inc. (NASDAQ: GTYH) shares climbed 115.2% to close at $6.09 as the company agreed to be acquired by GI Partners. Vaxxinity, Inc. (NASDAQ: VAXX)... 
Via Benzinga
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga

Performance

YTD
-39.67%
-39.67%
1 Month
-25.21%
-25.21%
3 Month
-28.97%
-28.97%
6 Month
-36.58%
-36.58%
1 Year
-8.04%
-8.04%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2022
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
52 Biggest Movers From Friday
Via Benzinga
30 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
50 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia at ASH 2021
From Imago BioSciences
Via Business Wire
Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Advanced Myelofibrosis at ASH 2021
From Imago BioSciences, Inc.
Via Business Wire
Mid-Day Market Update: Crude Oil Down 1%; Inspira Technologies Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
60 Biggest Movers From Yesterday
Via Benzinga
36 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
Via Benzinga
Exposures Product Safety
Imago BioSciences Appoints Laurie Keating to Board of Directors
From ​Imago BioSciences, Inc.
Via Business Wire
Imago BioSciences Announces Oral Data Presentations at the Upcoming 63rd American Society of Hematology Annual Meeting and Exposition
From Imago BioSciences, Inc.
Via Business Wire
Imago BioSciences Announces Its Addition to the Russell 2000® Index
From ​Imago BioSciences, Inc.
Via Business Wire
56 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
46 Biggest Movers From Yesterday
Via Benzinga
54 Biggest Movers From Yesterday
Via Benzinga
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
Via Benzinga
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.